Abstract
Lung cancer is one of the most common malignancies in the Western world, accounting for more cancer deaths than the next 4 most frequent cancers combined. In the year 2000, the worldwide incidence of non-small cell lung cancer was close to 1,000,000 cases; in 2004, there were approximately 174,000 cases of lung cancer in the United States alone, resulting in more than 160,000 deaths (1). The overall low 5-year survival rate for patients diagnosed with lung cancer (15%) is especially discouraging. Such poor long-term survival is probably related to the fact that early-stage disease is asymptomatic, and thus the onset of symptoms marks the presence of advanced, mostly incurable disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jemal RC, Tiwari T, Murray, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8–29.
Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Handbook. 6th edition. New York: Springer; 2002.
Nesbitt JC, Putnam JB, Walsh GL, Roth JA, Mountain CF. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg. 1995;60:466–472.
Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–1717.
Keller SM, Adak S, Wagner H, Johnson DH. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg. 2000;70:358–365 (discussion 365–366).
Naruke T, Goya T, Tsuchiya R, Suemasu K. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg. 1988;46:603–610.
Passlick B, Kubuschock B, Sienel W, et al. Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases—results of a preliminary study. Eur J Cardiothoacr Surg. 2002;21:520–526.
Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H. Lymph node sampling in lung cancer: how should it be done? Eur J Cardiothorac Surg. 1999;16:17–24.
Izbicki JR, Thetter O, Habekost M, et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Brit J Surg. 1994;81:229–235.
Allen MS, Darling G, Pechet T, et al. Morbidity and mortality of major pulmonary resections in patients with earlystage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 Trial. Ann Thorac Surg. 2006;81:1013–1019.
Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718–1723.
Little AG, DeHoyos A, Kirgan DM, et al. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. J Thorac Cardiovasc Surg. 1999;117:220–234.
Liptay MJ, Masters GA, Winchester DJ, et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg. 2000;70:384–389.
Nomori H, Horio H, Naruke T, Orikasa H, Yamazaki K, Suemasu K. Use of technetium-99m tin colloid for sentinel lymph node identification in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;1243:486–492.
Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K. In vivo identification of sentinel lymph nodes for clinical stage I non-small cell lung cancer for abbreviation of mediastinal lymph node dissection. Lung Cancer. 2004;46:49–55.
Melfi FM, Chella A, Menconi GF, et al. Intraoperative radioguided lymph node biopsy in non-small cell lung cancer. Eur J Cardiothorac Surg. 2003;23:214–220.
Lardinois D, Brack T, Gaspert A, et al. Bronchoscopic radioisotope injection for sentinel lymph-node mapping in potentially resectable non-small-cell lung cancer. Eur J Cardiothorac Surg. 2003;23:824–827.
Liptay MJ, Grondin SC, Fry WA, et al. Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastases. J Clin Oncol. 2002;20:1984–1988.
Kubuschock B, Passlick B, Izbicki JR, et al. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small cell lung cancer. J Clin Oncol. 1999;17:19–24.
Riquet M, Manac’h D, Pimpec-Barthes F, et al. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg. 1999;67:1572–1576.
Sugi K, Fukuda M, Nakamura H, Kaneda Y. Comparison of 3 tracers for detecting sentinel lymph nodes in patients with clinical N0 lung cancer. Lung Cancer. 2003;39:37–40.
Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001;182:393–398.
Nakagawa T, Minamiya Y, Katayose Y, et al. A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:563–567.
Minamiya Y, Ogawa J-I. The current status of sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 2005;11:67–72.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Boni, G., Manca, G., Melfi, F.M.A., Lucchi, M., Mussi, A., Mariani, G. (2008). Radioguided Biopsy of the Sentinel Lymph Node in Patients with Non-Small Cell Lung Cancer. In: Mariani, G., Giuliano, A.E., Strauss, H.W. (eds) Radioguided Surgery. Springer, New York, NY. https://doi.org/10.1007/978-0-387-38327-9_16
Download citation
DOI: https://doi.org/10.1007/978-0-387-38327-9_16
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-33684-8
Online ISBN: 978-0-387-38327-9
eBook Packages: MedicineMedicine (R0)